A detailed history of Quest Partners LLC transactions in Dexcom Inc stock. As of the latest transaction made, Quest Partners LLC holds 4,298 shares of DXCM stock, worth $292,736. This represents 0.07% of its overall portfolio holdings.

Number of Shares
4,298
Previous 749 473.83%
Holding current value
$292,736
Previous $104 Million 369.08%
% of portfolio
0.07%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$110.31 - $140.45 $391,490 - $498,457
3,549 Added 473.83%
4,298 $487 Million
Q1 2024

May 09, 2024

BUY
$114.22 - $140.1 $85,550 - $104,934
749 New
749 $104 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.